Ping An Health achieves enhancement in managed care healthcare
Cumulative paying users continue to increase Gross margin increased significantly to 27.3% HONG KONG and SHANGHAI, March 13, 2023 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or "Ping An Health"; Stock Code: 1833.HK) announced its 2022 annual results. The Company is committed to bridging doctors and patients with professionalism and safeguard everyone's health. With...
Annabella – the first breast pump to simulate a baby’s tongue, was launched in Israel, taking an estimated 10% of the monthly Israeli breast pump market, in February. The...
TEL AVIV, Israel, March 13, 2023 /PRNewswire/ -- Annabella, the world's first breast pump to simulate a baby's tongue during the pumping process, was recently launched in Israel after five years of development. The Annabella made its market debut on February 16, 2023, and quickly captured an estimated 10% share of the monthly sales in the Israeli breast pump...
Apollo Hospitals Group Completes 500 Pediatric Liver Transplants
A historic milestone, The Apollo Liver Transplant Program has a success rate of over 90% in pediatric liver transplantation Apollo Hospitals Delhi performed India's first successful pediatric liver transplant in 1998 The 500th child weighed only 4.6kg at the time of the transplant NEW DELHI, March 13, 2023...
Patient Enrollment Completed for the Phase 3 Trial of Boan Biotech’s Aflibercept Intravitreous Injection in China
YANTAI, China, March 13, 2023 /PRNewswire/ -- Luye Pharma Group today announced that patient enrollment has been completed for the Phase 3 clinical study (comparative clinical study of efficacy and safety) of BA9101 (Aflibercept Intravitreous Injection) in China. This is an investigational ophthalmic drug developed by the group's subsidiary Boan Biotech. The clinical study is being conducted by Boan Biotech...
Porton Advanced and Bennu Biotherapeutics Announced a Strategic Partnership to Accelerate Cell Therapy Development for Solid Tumors
SUZHOU, China, March 13, 2023 /PRNewswire/ -- On March 7th, 2023, Suzhou Porton Advanced Solutions Ltd. (Porton Advanced) and Bennu Biotherapeutics (Bennubio) announced a strategic partnership to advance cell and gene therapy R&D pipelines. The partnership aims to accelerate the development of T-cell therapies for tumors and autoimmune diseases. Porton Advanced and Bennu Biotherapeutics...
Zhongchao Inc. Releases Survey Results for Bone Marrow Cancer Patient Services with More than 80% Patients Indicating Full Satisfaction
SHANGHAI, March 13, 2023 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced the survey results of bone marrow patient services provided by Zhongxin Health, a platform of Shanghai Zhongxin Medical Technology Co., Ltd., one of the companies that Zhongchao consolidates...
Qritive Launches QAi Prostate: Advanced AI-Powered Prostate Cancer Diagnosis Tool for Pathologists
QAi Prostate leverages advanced machine learning algorithms to accurately identify and classify malignant and benign areas in prostate biopsies, improving diagnostic accuracy and patient outcomes SINGAPORE, March 13, 2023 /PRNewswire/ -- Qritive, a leading provider of digital pathology solutions, announced the launch of a new AI (Artificial Intelligence) module, QAi Prostate, for prostate cancer diagnosis. Using advanced machine...
Everest Medicines Announces Silicon Valley Bank Developments Have Minimal Impact on Company
SHANGHAI, March 13, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing, manufacturing and commercializing transformative pharmaceutical products and vaccines in Greater China and other parts of Asia, would like to announce that it considers its exposure to any liquidity concerns at Silicon Valley Bank (SVB) to be immaterial. The company's cash held at SVB...
AnnJi Pharmaceutical Announced A Licensing Agreement With Avenue Therapeutics To Develop And Commercialize AJ201, A First-In-Class Clinical Asset For The Treatment Of Kennedy’s Disease
TAIPEI, March 10, 2023 /PRNewswire/ -- AnnJi Pharmaceutical Co. (AnnJi) has entered into an exclusive license agreement with Avenue Therapeutics Inc. (Avenue, NASDAQ: ATXI) for the development and commercialization of AJ201 in the U.S., Canada, European Union, Great Britain, and Israel for spinal and bulbar muscular atrophy (SBMA), also known as Kennedy's Disease. Under the terms of the license...
Success for Surglasses Technology! First AR Surgery Completed in the United States
TAICHUNG, Taiwan, March 10, 2023 /PRNewswire/ -- Surglasses/Caduceus S from Taiwan Main Orthopaedic Biotechnology Co., Ltd. Achieves Landmark Success with Caduceus S AR Spine Navigation System for First Augmented Reality Surgery in the US using 2D C-Arm Imaging. Surglasses has achieved a significant milestone in the field of spinal surgery with the completion of the first augmented reality (AR) surgery in...
